Aigen Investment Management, LP Atara Biotherapeutics, Inc. Transaction History

Aigen Investment Management, LP

  • $440 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$14.0 - $20.72 $146,692 - $217,104
-10,478 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$12.67 - $26.23 $709,456 - $1.47 Million
-55,995 Reduced 84.24%
10,478 $206,000
Q3 2020

Nov 06, 2020
BUY
$11.92 - $15.87 $792,358 - $1.05 Million
66,473 New
66,473 $861,000

Others Institutions Holding ATRA

# of Institutions
87
Shares Held
85M
Call Options Held
18.4K
Put Options Held
51.3K
View Full List

About Atara Biotherapeutics, Inc.

ATRA Quotes by TradingView
  • Ticker ATRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,362,304
  • Market Cap $710M
  • Description
  • Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...
More about ATRA
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email